Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-01-30 00:00:00 ET · period of report 2025-01-28 · accession 0000950170-25-011242 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-01-30 | 2025-01-28 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale+OE | $36.29 | -68.0K | 93.8K | -42% | -$2.47M |
| DT | 2025-01-30 | 2025-01-28 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | $17.00 | +68.0K | 161.8K | +73% | +$1.16M |
| DT | 2025-01-30 | 2025-01-28 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | M - OptEx | $0.00 | -68.0K | 448.7K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-28 | S | D | 68,000 | $36.29 | 93,758 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $35.75 to $36.71 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-01-28 | M | A | 68,000 | $17.00 | 161,758 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-01-28 | M | D | 68,000 | $0.00 | 448,670 | D | $17.00 · — to 2029-06-26 | 68,000 Common Stock | (F3) The shares subject to this option vested in 48 equal monthly installments from June 26, 2019 to June 26, 2023. |